A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

PHASE4CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG

Esomeprazole

20mg Oral tablet once daily

DRUG

Esomeprazole

40mg Oral tablet once daily

DRUG

Placebo

Oral once daily